---
title: "一篇顶一万篇 | 肺癌数据集"
date: 2025-12-28T01:58:02Z
draft: ["false"]
tags: [
  "fetched",
  "医学僧的科研日记"
]
categories: ["Acdemic"]
---
一篇顶一万篇 | 肺癌数据集 by 医学僧的科研日记
------
<div><section><span data-pm-slice="0 0 []"><strong><span leaf="">"一篇顶一万篇"栏目</span></strong><span leaf="">，</span><span><span leaf="">书写经典、历久弥新的推文。</span></span></span></section><section data-role="uecloud-body" data-usign="30562" data-pm-slice="7 2 []"><section data-role="uecloud-body-main"><section data-role="uecloud" data-role-node="paragraph"><section><section><section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_gif/I1fyHmvzZiaX5oD1Bgk6NMQDadCzSN1MZPibIKOuzicZgtL1o4j2EYF97qyelWVde2giaMnHAibJibfBKrJicMKMiciawhw/640?from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;tp=webp&amp;wx_fmt=gif#imgIndex=0" alt="图片" data-ratio="1" data-w="512" data-imgfileid="100028843" src="https://mmbiz.qpic.cn/sz_mmbiz_gif/I1fyHmvzZiaX5oD1Bgk6NMQDadCzSN1MZPibIKOuzicZgtL1o4j2EYF97qyelWVde2giaMnHAibJibfBKrJicMKMiciawhw/640?from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;tp=webp&amp;wx_fmt=gif#imgIndex=0"></section><section><section><span leaf=""><br></span></section><section><section data-role-type="paragraph"><section data-role-type="text"><p><strong><strong><span data-pm-slice="0 0 []"><span leaf="">汇聚同道、前沿探索</span></span></strong><span data-pm-slice="0 0 []"><span leaf=""><br></span></span></strong></p><p><strong><strong><span leaf=""><br></span></strong></strong></p><p><span leaf=""><img data-croporisrc="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8cx2ib4YPJ6VvhHde2RT5sic7YdfeCVvrWdCc2LY4GibaUibRsF1rPQ0swXUb6AASZ4GoYhtMf5PicE3ibg/0?wx_fmt=jpeg&amp;from=appmsg" data-cropx1="195.84699453551914" data-cropx2="1095.8105646630238" data-cropy1="448.817537236938" data-cropy2="1604.580832608742" data-imgfileid="100028866" data-ratio="1.2844444444444445" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8cx2ib4YPJ6VvhHde2RT5sic7sxrSDRJrywqmO7mkHg6tic1FXM3OEvB0eQaq4YTKk9ia4x7Hz6mUiamtQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="900" src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8cx2ib4YPJ6VvhHde2RT5sic7sxrSDRJrywqmO7mkHg6tic1FXM3OEvB0eQaq4YTKk9ia4x7Hz6mUiamtQ/640?wx_fmt=jpeg"></span></p><p><strong><span leaf=""><span textstyle="">科研交流群</span></span></strong></p><p><strong><span leaf=""><span textstyle="">请扫描上方二维码</span></span></strong></p></section></section></section></section></section></section></section></section></section></section><p data-pm-slice="0 0 []"><span leaf=""><br></span></p><section><p data-pm-slice="0 0 []"><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"data-pm-slice":"0 0 []"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span textstyle="">今天推文四篇，</span></span><span leaf="" data-pm-slice='1 1 ["para",null,"para",{"tagName":"p","attributes":{"data-pm-slice":"0 0 []"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span textstyle="">完成了</span></span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"data-pm-slice":"0 0 []"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span textstyle="">前几天留言中想让Sogen帮忙找数据集的评论请求，如有想检索的疾病数据集，欢迎在Sogen推文下方评论。</span></span></p></section><section><span leaf=""><br></span></section><section nodeleaf=""><img data-imgfileid="100028885" data-ratio="0.5453703703703704" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8cx2ib4YPJ6VvhHde2RT5sic7TXRMdeP0zVAicsZGu9afJibQoHE2aOFNGibhXdWiaG7A2yu0O3icvm7swiaw/640?wx_fmt=jpeg&amp;from=appmsg" data-type="png" data-w="1080" type="block" src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8cx2ib4YPJ6VvhHde2RT5sic7TXRMdeP0zVAicsZGu9afJibQoHE2aOFNGibhXdWiaG7A2yu0O3icvm7swiaw/640?wx_fmt=jpeg&amp;from=appmsg"></section><p data-pm-slice="0 0 []"><span leaf=""><br></span></p><p data-pm-slice="0 0 []"><span leaf=""><span textstyle="">GSE274975</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-sequencing</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 61 (未明确分组)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在提高对肺癌的理解，通过高通量测序技术对61例肺癌组织样本进行了RNA测序。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE268175</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 67 (34 肿瘤 vs 33 癌旁)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究收集了34例早期非小细胞肺癌组织及其配对的癌旁非癌组织，利用RNA-seq技术进行转录组测序，旨在通过差异表达分析、孟德尔随机化及免疫浸润分析，鉴定与肺癌相关的关键基因和信号通路，并探索巨噬细胞M1在其中的作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE165298</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12 (3 tumor vs 3 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究针对三名不吸烟的宣威女性肺腺癌患者，采集其肿瘤组织及配对癌旁正常组织，进行了全面的转录组、蛋白质组和磷酸化蛋白质组等多组学分析，旨在系统揭示宣威肺腺癌的分子机制，并识别与氧化磷酸化和免疫功能障碍相关的潜在治疗靶点。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE159857</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 58 (具体分组信息未明确)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究对非小细胞肺癌（包括肺腺癌和肺鳞癌）进行多组学分析，旨在通过系统生物学方法全面揭示肺腺癌和肺鳞癌特有的分子扰动，以发现新的治疗靶点。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE193725</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 54 (纯非实性结节 vs 实性结节)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究为探究肺癌进展过程中肿瘤微环境的变化，通过计算机断层扫描（CT）将样本分为两组，一组为包含癌前/微浸润性癌的纯非实性密度结节，另一组为浸润性癌的实性密度结节，利用高通量测序技术进行表达谱分析，揭示了从癌前状态到浸润性肿瘤过程中肿瘤与微环境之间的动态相互作用及免疫抑制特征的演变。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE180347</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Nanostring nCounter Pan Cancer Immune Profiling Panel</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 144 (138 tumor vs 6 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究聚焦于肺腺癌，旨在探究肿瘤PD-L1表达状态及免疫浸润程度与免疫细胞浸润格局的关系，通过免疫组化分析138例具有“热”或“冷”免疫表型及PD-L1阳性或阴性表达的肺腺癌肿瘤样本中PD-L1、CD4和CD8的表达，并利用Nanostring nCounter技术进行转录组分析，以鉴定与不同表型相关的差异表达基因，从而为免疫治疗反应分层提供新见解。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE181820</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: High throughput sequencing</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 22</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在探索高肿瘤突变负荷的非小细胞肺癌中WNT/β-catenin信号通路激活导致肿瘤微环境缺乏CD8+ T细胞浸润及对PD-1阻断疗法耐药的机制，通过对相关样本进行高通量测序以分析基因表达谱。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE148801</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 30</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究针对肺腺癌，通过免疫组化分析临床样本中HTR3A表达与侵袭性组织学亚型（腺泡型、乳头型、实体型）及增殖标志物Ki-67的关系，并构建HTR3A敲低的肺腺癌细胞系，证明其通过ERK磷酸化途径促进增殖，同时探讨了5-HT3受体拮抗剂托烷司琼的治疗潜力。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE116959</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 微阵列 (Expression profiling by array)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 68 (57 肺腺癌 vs 11 癌旁正常肺组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 从57名肺腺癌患者和同一队列患者的11份距离肿瘤标准距离（3厘米）的正常肺组织中提取RNA，使用微阵列技术进行转录组分析，旨在研究肺腺癌的基因表达谱。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE130779</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Agilent microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16 (8 tumor vs 8 adjacent non-tumor)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集8例肺腺癌患者的肿瘤组织及其配对癌旁非肿瘤组织，使用Agilent微阵列芯片进行全基因组lncRNA和mRNA表达谱分析，旨在鉴定肺腺癌相关的差异表达基因。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE118370</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12 (6 tumor vs 6 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集肺腺癌组织及其配对的正常肺组织，使用微阵列技术进行表达谱分析，旨在鉴定在侵袭性肺腺癌中上调的基因，以发现新的分子调控因子和潜在治疗靶点。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE101929</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 66 (41 tumor vs 25 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究利用mRNA和microRNA表达谱芯片，对来自非洲裔美国人（AA）和欧洲裔美国人（EA）的非小细胞肺癌患者的配对新鲜冷冻肿瘤组织与正常肺组织进行比较分子分析，旨在探究种族间的基因和miRNA表达差异是否转化为具有临床相关性的肺癌肿瘤生物学差异，并评估其对预测药物反应和肿瘤微环境的影响。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE90728</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 68 (肿瘤组织 vs 癌旁非肿瘤组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对未经治疗的早期肺癌患者的肿瘤组织及配对癌旁非肿瘤组织中的细胞毒性T淋巴细胞进行全局转录组分析，旨在定义与抗肿瘤免疫反应强度相关的分子特征，并发现与组织驻留记忆细胞特征相关的CD103高表达与患者更长生存期相关。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE85841</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Agilent microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16 (8 tumor vs 8 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集8例肺腺癌患者的肿瘤组织及其配对的癌旁非肿瘤组织，使用Agilent微阵列芯片进行全基因组基因表达谱分析，以研究肺腺癌的基因表达特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE89039</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Gene expression microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16 (8 tumor vs 8 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集8例宣威肺癌肿瘤组织及其配对的非癌肺组织，使用基因表达微阵列技术进行转录组分析，旨在筛选宣威肺癌中潜在的新驱动基因。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE75037</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 微阵列</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 166 (83 tumor vs 83 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 收集83例肺腺癌肿瘤组织及其配对的非恶性癌旁肺组织，利用微阵列技术进行基因表达谱分析，旨在开发用于辅助非小细胞肺癌常规病理学分型的RNA表达特征谱，并区分肿瘤与非恶性组织。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE74706</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray (Expression profiling by array)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 36 (NSCLC vs tumor-free lung)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 从患者样本中分离RNA，通过微阵列技术检测配对的无瘤肺组织和非小细胞肺癌组织标本中TGFb通路基因的表达差异。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE63074</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 微阵列芯片</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 410 (预后差 vs 预后好)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对早期、完全切除的非小细胞肺癌患者进行基因表达谱分析，旨在验证一个包含15个基因的预后特征，该特征能够区分预后良好和预后不良的患者。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE43458</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Human Gene 1.0 ST array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 110 (80 tumor vs 30 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对80例肺腺癌组织和30例正常肺组织进行基因表达谱芯片分析，旨在深入了解这种在非小细胞肺癌中占重要比例的亚型的生物学特性，以加强对此恶性肿瘤的认知。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE30219</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 微阵列芯片 (Expression profiling by array)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 307 (293 肿瘤 vs 14 正常)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究分析了293例肺癌肿瘤组织与14例正常肺组织样本的转录组数据，旨在通过识别组织特异性基因的异常“脱背景”表达模式，发现与不良预后和转移倾向相关的生物标志物，为肺癌的个性化管理提供新策略。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE21933</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Phalanx Human OneArray chip</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 42 (21 tumor vs 21 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 收集21例原发性非小细胞肺癌患者的肿瘤组织及其配对的正常肺组织，使用Phalanx Human OneArray芯片进行全基因组表达谱分析。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE37764</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序 (RNA-seq)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 36 (6 tumor vs 6 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究针对6例从不吸烟的韩国女性非小细胞肺腺癌患者，采集其原发性肿瘤组织及配对癌旁正常组织，利用RNA-seq技术进行转录组测序，旨在整合基因组、转录组和表观遗传学数据，鉴定新的遗传畸变（如体细胞突变和融合转录本），并构建功能网络以揭示关键的失调通路，特别是G2/M细胞检查点调控模块。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE27262</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 50 (肿瘤 vs 癌旁正常组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究聚焦于非小细胞肺癌的肿瘤组织与配对癌旁正常组织之间的基因表达特征差异。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE32665</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 179 (92 tumor vs 87 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究采集了92例肺腺癌患者的配对肿瘤组织及正常肺组织样本，利用基因表达谱芯片技术进行分析，旨在识别正常肺组织中与特定细胞谱系相关的基因网络，并阐明这些网络在向肺腺癌转化过程中的重编程变化，以发现新的潜在治疗靶点。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE10445</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 微阵列</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 72 (72 tumor vs 0 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 收集72例IB期肺腺癌和大细胞肺癌的肿瘤组织样本，旨在利用拷贝数驱动的基因表达特征来预测患者预后。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE7880</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Human HG Focus Array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 43 (20 primary tumor vs 23 recurrent tumor)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为鉴定与肺癌进展相关的基因，本研究比较了20例未经治疗的原发性非小细胞肺癌患者（10例腺癌和10例鳞癌）的肿瘤细胞与23例IIIB期或IV期非小细胞肺癌患者（15例腺癌和8例鳞癌）的复发肿瘤组织的基因表达谱，所有肿瘤细胞均通过激光捕获显微切割技术分离以确保纯度，并使用Affymetrix微阵列芯片进行分析，旨在揭示从原发性肿瘤进展至复发过程中的差异表达基因和信号通路。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE6044</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Human HG Focus Array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 47 (34 肺癌 vs 5 正常肺组织 + 8 验证样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在通过基因表达谱对肺癌进行分子分型和表征，使用激光捕获显微切割技术从29例未经治疗的肺癌患者（包括10例腺癌、10例鳞状细胞癌、9例小细胞肺癌）中纯化肿瘤细胞，并与5例无肿瘤对照患者的正常肺组织进行比较，采用Affymetrix微阵列芯片检测基因表达，以鉴定不同肺癌亚型与正常组织间的差异表达基因，并构建分类器进行亚型鉴别。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE233203</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 7</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对最终获得EGFR-TKI耐药的非小细胞肺癌患者，采用靶向癌细胞和基质细胞的阿特珠单抗联合贝伐珠单抗及卡铂/紫杉醇（ABCP）方案进行治疗。为解析与ABCP治疗反应相关的肿瘤微环境及调控机制，对接受ABCP治疗的患者样本进行了单细胞RNA测序分析。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE300685</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 8 (肺腺癌样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对来自非吸烟者、吸烟者、慢性阻塞性肺疾病患者以及8例浸润性肺腺癌患者的共61份肺组织样本进行单细胞RNA测序，以定义与吸烟相关的免疫特征，并利用102例已切除的非小细胞肺癌和24例接受新辅助化疗免疫治疗的NSCLC患者的RNA测序数据进行计算反卷积分析，旨在评估肿瘤浸润自然杀伤细胞表型与临床结局的关联，为吸烟NSCLC患者的治疗分层提供依据。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE281964</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 4</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在探究肺腺癌中谱系可塑性的分子机制，重点关注由肺谱系决定因子NKX2-1与胃肠道转录调节因子HNF4α共同表达所诱导的促肿瘤混合身份状态。通过对小鼠模型进行单细胞RNA测序，揭示了HNF4α通过直接激活其经典靶点驱动肿瘤生长和混合身份状态，并受RAS/MEK信号通路维持，同时发现抑制该通路会增强NKX2-1的染色质结合并诱导与耐药相关的肺谱系特征，最终证明HNF4α耗竭可使肺腺癌细胞对KRASG12D抑制敏感。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE299111</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序 (Expression profiling by high throughput sequencing)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 7</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究在人和小鼠肺癌模型中，探讨化疗后肿瘤微环境中调节性T细胞（Tregs）与髓系细胞的相互作用。通过分析化疗后肿瘤微环境中髓系景观的变化，发现其诱导了短暂的促炎性单核细胞积累，并伴随TGFβ表达增加。研究进一步揭示了Tregs在促进髓系细胞抗炎极化中的作用，并探索了靶向TNFR2以干扰Tregs与髓系细胞互动的治疗策略，旨在为免疫检查点阻断疗法提供替代或补充方案。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE285888</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 1 (非小细胞肺癌患者治疗前外周血单个核细胞)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对接受免疫检查点抑制剂治疗前的非小细胞肺癌患者外周血单个核细胞进行单细胞RNA测序，旨在识别能够预测免疫治疗疗效和免疫相关不良事件风险的生物标志物，为优化个体化免疫治疗策略提供依据。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE291670</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6 (3 MPR vs 3 Non-MPR)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为探索新辅助安罗替尼联合PD-1阻断疗法在晚期非小细胞肺癌中的耐药机制并预测患者反应，对6例接受该联合治疗的患者进行单细胞RNA测序，其中3例为治疗后达到主要病理缓解的患者，3例为未达到主要病理缓解的患者，以观察和分析免疫细胞、基质细胞及癌细胞的动态变化，并在独立队列中进行了验证。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE266035</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA/TCR-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 1例患者（纵向采样）</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对一例对PD-1/CTLA-4联合阻断疗法产生应答后又进展的非小细胞肺癌患者，纵向采集其外周血样本，进行单细胞RNA/TCR测序，以分析循环T细胞的基因表达和T细胞受体动力学。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE190905</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16 (早期非小细胞肺癌患者，接受SBRT或联合抗PD-1治疗)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对早期非小细胞肺癌患者外周血单个核细胞进行单细胞RNA测序和TCR测序，比较接受立体定向体部放疗（SBRT）与放疗联合抗PD-1治疗（ISBRT）前后T细胞亚群和TCR库的动态变化，以揭示不同治疗方案诱导的系统性免疫应答差异。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE243013</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 234例患者</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对234例非小细胞肺癌患者接受新辅助化疗联合免疫治疗（抗PD(L)1）后的肿瘤样本进行单细胞RNA和TCR测序，旨在精细解析与治疗反应相关的肿瘤免疫微环境异质性，为改善非小细胞肺癌的治疗管理提供资源。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE280433</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 8</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 从接受手术且尚未进行化学免疫治疗的非小细胞肺癌患者肿瘤组织中分离CD8阳性T淋巴细胞，进行单细胞RNA测序分析。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE205335</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 33 (接受免疫检查点抑制剂治疗的肺癌患者)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对接受免疫检查点抑制剂治疗的肺癌患者的肿瘤组织进行单细胞RNA测序，旨在鉴定与免疫治疗反应相关的肿瘤特征和免疫细胞图谱。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE268426</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 10X Genomics FLEX (snPATHO-seq)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 37</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究开发了一种名为snPATHO-seq的新型单核RNA测序流程，用于处理福尔马林固定石蜡包埋组织样本，利用从FFPE样本中分离的高质量细胞核和10X Genomics FLEX化学方法。该流程与成熟的10X Genomics 3'检测性能一致，并能够更准确地将来自同一FFPE蜡块的单核转录组数据与FFPE Visium空间转录组数据集进行整合，旨在促进对海量FFPE存档样本的转录组解读。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE271872</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 8 (Gprc5a-/- vs Gprc5a-/-; Lcn2-/- 模型)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在阐明肠道菌群改变对肺腺癌（LUAD）肿瘤发生和免疫反应的影响。使用Gprc5a-/-小鼠模型，通过粪便菌群移植（FMT）技术，将来自Gprc5a-/-和Gprc5a-/-; Lcn2-/-供体的菌群移植给受体，以探究肠道菌群变化在调节肿瘤生长和免疫微环境中的作用。对结肠固有层和皮下肿瘤组织进行了单细胞RNA测序（scRNA-seq）。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE194070</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序 (scRNA-seq)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16 (NSCLC伴COPD患者与不伴COPD患者的肿瘤组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为阐明慢性阻塞性肺疾病（COPD）与非小细胞肺癌（NSCLC）间的复杂相互作用，本研究对来自NSCLC伴COPD患者的肿瘤组织进行单细胞RNA测序，全面表征了恶性细胞的转录组谱和免疫细胞动态，旨在揭示CD74+癌细胞介导免疫逃逸的机制及其作为免疫治疗靶点的潜力。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE274</span></span><span leaf=""><span textstyle="">477</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 4</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对表达Kras癌基因的小鼠肺泡2型细胞进行单细胞RNA测序，旨在识别肿瘤发生早期由KRAS癌蛋白表达导致的功能性改变，特别是I型干扰素通路受损，并研究恢复该通路信号如何将肿瘤微环境从“冷”转变为“热”，从而增强KRAS突变肺肿瘤对免疫治疗的敏感性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE267108</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究通过单细胞测序对肺腺癌样本进行分析，旨在探究患者免疫逃逸的分子机制，以开发预测和治疗靶点。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE253658</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 5</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用EGFR突变肺腺癌的基因工程小鼠模型，通过高分辨率转录组学系统分析肿瘤异质性演变及肿瘤微环境中细胞间的动态相互作用，并评估微管结合剂Unesbulin治疗对肿瘤特异性上皮细胞及其与内皮细胞、成纤维细胞和肿瘤浸润免疫细胞等生态位成分间互作界面的影响，同时结合MRI分析证实肿瘤生长减缓。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE222901</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 35 (Gprc5a-/-小鼠)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对Gprc5a-/-小鼠在肺肿瘤发生发展过程中的肺组织进行单细胞RNA测序，并结合荷瘤肺组织的空间转录组学分析，旨在解析早期肺腺癌发展的细胞过程，为制定干预策略提供依据。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE164789</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 78</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对肺腺癌前驱病变组织进行多组学分析，包括单细胞RNA转录组测序、单细胞T细胞受体测序、全外显子组测序和多重免疫组化，旨在解析肺腺癌前驱病变的单细胞图谱及免疫细胞在病变发展过程中的作用机制，以挖掘潜在的治疗靶点。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE198099</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 10X Genomics</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 2例患者（包含肿瘤组织、远端正常组织及淋巴结组织）</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对2例非小细胞肺癌患者的肿瘤组织、远端正常组织及淋巴结组织进行10X Genomics单细胞转录组测序，共分析43779个细胞，旨在探究肿瘤微环境中免疫抑制性细胞亚群（如免疫抑制性B细胞、耗竭T细胞、肿瘤相关巨噬细胞等）的分子特征及其在肿瘤进展中的作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE235602</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序 (scRNA-seq)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 52</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究整合了来自抗PD-1治疗和未经治疗的非小细胞肺癌（NSCLC）小鼠模型的超过73,000个肿瘤浸润调节性T细胞（TIL-Treg）的单细胞RNA测序和TCR测序数据，旨在解析Treg在免疫检查点阻断治疗反应中的异质性作用，并鉴定出具有不同转录谱和功能的Treg亚群，特别是发现表达OX40和GITR的抑制性亚群与PD-1阻断耐药相关，而肿瘤相关抗原特异性Treg则呈现Th1样特征并与治疗反应相关。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE229253</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: snRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 33 (肿瘤癌旁组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对33例早期肺腺癌患者的癌旁正常肺组织进行单核RNA测序，旨在分析其转录组特征，以预测肺癌患者的复发风险。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE203447</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 3</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 在由肺上皮中致癌KrasG12D表达诱导形成肺肿瘤的小鼠模型中，基于新型基因工程等位基因p16FDR/+，通过Cdkn2a (p16) 位点控制表达的mCherry报告基因，利用流式细胞分选技术分离肺微环境中的假定衰老细胞及其非衰老对应细胞，进行单细胞RNA测序，以研究肿瘤微环境中衰老细胞的特征及其对肿瘤进展的促进作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE226597</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序 (scRNA-seq)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 3</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用携带KrasG12D突变的肺腺癌小鼠模型，通过单细胞RNA测序分析胆固醇外排通路缺陷对肺肿瘤细胞多样性的影响。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE229353</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 7 (接受新辅助化疗联合PD-1抑制剂治疗或单独化疗的非小细胞肺癌患者)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 从7例接受新辅助化疗或新辅助化疗联合帕博利珠单抗治疗的非小细胞肺癌患者的手术切除新鲜肿瘤组织中分选CD45+免疫细胞进行单细胞RNA测序，旨在阐明PD-1抑制剂增强化疗效果的免疫机制，并利用多重荧光免疫组化在65例患者的配对FFPE组织中进行验证。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE215992</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 2</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过构建肺泡巨噬细胞中Siah1a/2泛素连接酶基因敲除的小鼠模型，研究其在氨基甲酸乙酯诱导的肺腺癌发生中的作用，利用单细胞RNA测序分析巨噬细胞分化状态与肿瘤微环境的关联，揭示Siah1a/2通过调控巨噬细胞成熟和促纤维化表型影响肺癌发展的机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE164146</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12 (非小细胞肺癌患者来源)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对非小细胞肺癌患者来源的肿瘤浸润调节性T细胞进行单细胞RNA与T细胞受体联合测序分析，通过比较具有独特TCR克隆型和扩增TCR克隆型的Treg细胞的基因表达，鉴定抗原反应性Treg的转录特征，旨在阐明TCR依赖性Treg激活与分化的调控机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE218258</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 2</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究利用CD39的细胞表面表达，证明该标记物可富集具有耗竭、增殖和肿瘤反应性特征的CD8+ T细胞，旨在鉴定肺癌患者中的肿瘤反应性CD8 T细胞。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE216086</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 未明确指定（需进一步确认）</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究通过高通量测序分析，探究了调节性T细胞在肺腺癌中通过抑制1型常规树突状细胞来诱导CD8+ T细胞功能失调反应的机制，发现这种免疫调节作用在组织特异性淋巴结微环境中发生空间协调，并需要DC1与Tregs之间的抗原特异性接触，其中抑制性克隆扩增的TH1样效应Tregs在肺淋巴结中因组织特异性干扰素-γ水平而被差异性诱导。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE211068</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 9</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对来自人肺癌等肿瘤微环境中的调节性T细胞进行整合多组学分析，通过单细胞RNA测序结合其他组学数据，揭示了肿瘤微环境中Treg细胞特异的染色质开放特征和分化程序，旨在识别调控Treg细胞分化的关键转录因子，为开发Treg细胞靶向疗法提供依据。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE183219</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 27 (15例患者的配对肿瘤与癌旁组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对15例非小细胞肺癌患者的配对肿瘤组织与癌旁组织进行聚焦于基质细胞的单细胞测序，结合拓扑学分析，旨在鉴定与T细胞排斥相关的癌症相关成纤维细胞亚群。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE150938</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 应用单细胞RNA测序技术解析人肺磨玻璃结节的多细胞生态系统，研究细胞间相互作用，并探索肿瘤反应与特定临床因素之间的相关性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE200972</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 19例多原发肺癌患者</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过单细胞RNA测序构建多原发肺癌的细胞图谱，旨在解析同一患者内不同病灶间的异质性，以应对临床诊断与治疗挑战。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE198291</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 8例患者（包含循环肿瘤细胞、原发灶及转移灶样本）</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对1例肺腺癌患者的循环肿瘤细胞、原发肿瘤组织和脑转移瘤组织进行单细胞转录组测序，以鉴定转移相关生物标志物；随后对另外7例患者的原发或转移性肺腺癌组织进行单细胞测序验证，旨在单细胞层面解析肺癌脑转移机制，并揭示RAC1在肺腺癌脑转移中的作用及相关通路。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE179501</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 4</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究利用Lkb1XTR等位基因构建小鼠模型，在KRAS驱动的已形成肺肿瘤中，通过他莫昔芬诱导恢复Lkb1功能，对经FACS分选的总活细胞进行单细胞RNA测序，旨在探究LKB1肿瘤抑制因子恢复如何影响肿瘤细胞状态和组成，发现Lkb1恢复主要驱动上皮细胞向肺泡II型细胞命运重编程。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE179994</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 47份活检样本 (来自36例非小细胞肺癌患者，治疗前及治疗中)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对36例非小细胞肺癌患者在PD-1抑制剂联合化疗治疗前及治疗期间采集的共47份临床肿瘤活检组织进行时序性单细胞RNA和配对T细胞受体测序，以研究治疗响应与无响应肿瘤中T细胞亚群的动态变化，揭示抗PD-1疗法诱导肿瘤排斥的机制，重点关注耗竭前体T细胞的克隆复兴与扩增。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE136246</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens; Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 31 (人类腺癌与小鼠模型)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对携带KRAS突变的侵袭性人类肺腺癌及可比的小鼠模型进行单细胞RNA测序，以解析肿瘤异质性，鉴定出一个肿瘤特异性、与突变KRAS相关的保守细胞亚群；并在小鼠模型中研究了影响BMI-1活性的PTC596体内治疗效果，治疗后MRI显示肿瘤缩小，单细胞转录组学检测到该突变KRAS相关亚群几乎完全消失，表明存在一个可药物靶向的肿瘤相关亚群。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE176021</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: single-cell RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 110 (未明确区分疾病组与对照组)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对接受新辅助PD-1阻断治疗的肺癌患者样本，通过MANAFEST方法鉴定突变相关新抗原特异性T细胞克隆，并利用其TCR CDR3序列作为条形码，结合单细胞RNA测序在肿瘤微环境中追踪并分析这些克隆的转录程序和功能，旨在揭示PD-1阻断治疗应答与非应答患者中新抗原特异性T细胞的独特转录特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE146100</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 3 (1例患者的多发肺结节)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对一例接受帕博利珠单抗治疗的多原发肺腺癌患者的多个肺结节进行整合多组学分析，包括单细胞RNA测序，以研究免疫治疗应答与不应答结节在免疫微环境、基因组变异和细胞亚群（如组织驻留记忆T细胞、巨噬细胞亚型）方面的差异，揭示潜在的免疫应答机制和耐药机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE147580</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 8</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为探索非小细胞肺癌病灶中髓系细胞区室的多样性，对CD45+肿瘤相关白细胞进行了无偏见的单细胞RNA测序分析，识别了人源肿瘤中富集的特定巨噬细胞群，并在小鼠肺肿瘤中发现了相关表型，通过谱系追踪揭示了这些不同巨噬细胞群在起源、时间和肿瘤微环境空间分布上的差异，并发现组织驻留巨噬细胞在肿瘤细胞植入早期促进其上皮间质转化和侵袭性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE162499</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq &amp; scTCR-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12 (11例患者)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对11例未经治疗的原发性非小细胞肺癌患者的肿瘤组织、癌旁组织及外周血样本进行单细胞RNA与TCR联合测序，旨在解析肿瘤浸润CD8+ T细胞的分化过程，并比较循环前体与组织驻留前体细胞对终末效应T细胞池的贡献。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE162498</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA和TCR测序 (scRNA-seq &amp; scTCR-seq)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 17 (11例患者，包含肿瘤、癌旁组织和外周血样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对11例未经治疗的原发性非小细胞肺癌患者的肿瘤组织、癌旁正常组织及外周血进行单细胞RNA和TCR测序，旨在通过整合转录组和TCR谱系描绘肿瘤浸润CD8+ T细胞的分化过程，揭示循环前体与驻留前体对肿瘤内CD8+ T细胞群的贡献。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE148071</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 42</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对晚期非小细胞肺癌样本进行单细胞RNA测序，以表征每个细胞的基因表达模式，从而全面解析整个肿瘤生态系统。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE148466</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Drop-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 3 (3例NSCLC肿瘤)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对3例不同患者新鲜切除的非小细胞肺癌组织进行Drop-seq单细胞RNA测序，旨在解析肿瘤细胞异质性，识别不同的肿瘤细胞亚群，并评估区分癌细胞与组织中其他细胞的基因的临床价值。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE152022</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 未明确指定</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 4</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究通过高通量测序比较了肿瘤浸润调节性T细胞与其他T细胞亚群的转录组，发现IL-33受体ST2是驱动Treg在肿瘤微环境中优先增殖和积累的关键因子，其信号通路促进了肿瘤进展。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE154989</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 7282个细胞</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对基因工程小鼠肺肿瘤从非典型腺瘤性增生到腺癌的七个阶段进行单细胞转录组测序，追踪肿瘤从单细胞发展为恶性异质性组织的演化过程，揭示了高可塑性细胞状态的出现及其与肿瘤异质性、化疗耐药和患者不良预后的关联。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE154977</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 4 (多阶段肿瘤演进样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对基因工程小鼠肺肿瘤从非典型腺瘤性增生到腺癌的七个演进阶段进行单细胞转录组测序，揭示了肿瘤内异质性随时间增加，并鉴定出一个与化疗耐药相关的高可塑性细胞状态。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE154826</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: CITE-seq (单细胞RNA测序与表面蛋白检测)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 35例早期非小细胞肺癌病灶</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对35例早期非小细胞肺癌病灶的免疫细胞进行多尺度单细胞测序分析，包括单细胞RNA测序、CITE-seq和TCR测序，旨在研究免疫治疗背景下的肿瘤免疫微环境。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE153935</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 18例</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究利用单细胞RNA测序和多重免疫组化技术，分析了人肺组织与非小细胞肺癌样本中的成纤维细胞异质性，鉴定了包括炎症性成纤维细胞、肌成纤维细胞、静息成纤维细胞等在内的七个亚群，并发现这些亚群在组织中呈离散分布，其分化状态与特定微环境相关，旨在解析NSCLC中成纤维细胞的亚型与分化机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE145896</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞分析</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 8</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 从非小细胞肺癌患者中获取肿瘤浸润CD8+ T细胞，通过单细胞分析比较CD28+与CD28–亚群对PD-1阻断的响应差异，发现CD28表达缺失是PD-1阻断无应答的标志，并探索了IL-15联合治疗的潜力。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE131907</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 58例样本（来自44例患者）</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对来自44例肺腺癌患者的58份样本（包括原发肿瘤、淋巴结和脑转移灶、胸腔积液以及正常肺组织和淋巴结）中的208,506个细胞进行单细胞RNA测序，描绘了包含癌细胞、基质细胞和免疫细胞的复杂细胞图谱，以研究肺腺癌进展过程中的肿瘤微环境。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE143423</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 4 (3 非小细胞肺癌 vs 1 三阴性乳腺癌)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对3例未经治疗的非小细胞肺癌患者手术切除的脑转移灶以及1例三阴性乳腺癌患者的脑转移灶进行大规模平行单细胞RNA测序，共分析了12,196个细胞，旨在揭示转移性脑肿瘤微环境中肿瘤浸润免疫细胞的复杂性，重点关注肿瘤相关巨噬细胞的表型及其对T细胞反应的影响。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE129297</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 4 (不同治疗组)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对携带小细胞肺癌肿瘤的小鼠肺组织进行单细胞RNA测序，分析小鼠在接受CDK7抑制剂YKL、抗PD-1抗体以及联合治疗后的肿瘤微环境变化。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE99254</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 14例非小细胞肺癌患者</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对14例未经治疗的非小细胞肺癌患者的肿瘤组织、癌旁正常组织和外周血中的12346个T细胞进行深度单细胞RNA测序，描绘了肺癌中肿瘤浸润淋巴细胞的组成、谱系和功能状态基线图谱，旨在解析肿瘤-免疫相互作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE97168</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: MARS-Seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 2 (1 tumor vs 1 adjacent normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对一例IA期肺腺癌患者的肿瘤病灶及癌旁非受累肺组织中的非淋巴细胞免疫细胞进行分选，利用MARS-Seq进行大规模平行单细胞RNA测序，通过无偏的单细胞转录组分析捕获肿瘤浸润髓系细胞区室的异质性，旨在揭示早期肺腺癌的天然免疫景观。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE271689</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Digital Spatial Profiling (DSP–GeoMx–WTA)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 586例患者</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究采用空间多组学方法，结合Phenocycler Fusion的单细胞分辨率空间蛋白质组学与DSP-GeoMx全转录组分析，对接受一线免疫治疗的晚期非小细胞肺癌患者的组织样本进行肿瘤免疫微环境表征，旨在开发预测免疫治疗结局的空间模型并识别新的生物标志物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE265899</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: NanoString GeoMx DSP</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 95例（根据肿瘤PD-L1表达状态及免疫微环境状态进行空间匹配区域分析）</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究利用数字空间分析仪，根据肿瘤PD-L1表达水平和免疫微环境状态，对肺癌组织内空间匹配区域的肿瘤细胞和免疫细胞进行了蛋白质组学和全转录组学分析，旨在解析肿瘤微环境中与PD-L1表达及免疫细胞浸润相关的空间特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE216055</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: SlideSeq V2</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 3 (1 非小细胞肺癌 vs 2 皮肤/葡萄膜黑色素瘤)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究提供了来自KEYNOTE-001试验的三个连续活检样本（一个治疗前和两个治疗中）的5'单核RNA测序数据，这些样本来自冷冻标本，并配套提供了匹配的SlideSeq V2空间转录组数据，旨在建立一个应用于临床级别标本的单核RNA测序框架。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE200916</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 空间转录组测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12例</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究针对临床诊断与治疗具有挑战性的多原发性肺癌，通过空间转录组测序技术，描绘了多原发性肺癌的细胞图谱与空间结构。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE174749</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: NanoString GeoMx DSP</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 191个感兴趣区域 (ROIs)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对一例非小细胞肺癌肿瘤样本进行高密度空间基因表达谱分析，使用GeoMx癌症转录组图谱mRNA检测技术，共分析了191个感兴趣区域，旨在为空间解析基因表达数据中的细胞类型定量提供研究基础。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE174743</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: NanoString GeoMx DSP</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 191个感兴趣区域 (来自1例NSCLC肿瘤)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究使用GeoMx癌症转录组图谱mRNA检测方法，对一例非小细胞肺癌肿瘤样本的191个感兴趣区域进行了密集的空间基因表达谱分析，旨在提供高分辨率的肿瘤空间转录组数据。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE149957</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 52 (CAFs vs NFs)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究从非小细胞肺癌患者中分离出癌症相关成纤维细胞（CAFs）及其配对的正常成纤维细胞（NFs），利用甲基化芯片和转录组进行联合分析，旨在量化肿瘤微环境的恶性程度；研究发现大量CAF/NF差异甲基化CpG位点，其中吸烟者变化更显著，并基于54个吸烟相关CpG位点构建了用于区分NF/CAF的甲基化指数（MIND），该指数在预测肿瘤复发方面显示出潜力。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE277078</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Infinium MethylationEPIC BeadChip (Illumina)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 185 (非小细胞肺癌患者血浆游离DNA样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究使用Illumina EPIC甲基化芯片对185例非小细胞肺癌患者的血浆游离DNA样本进行全基因组DNA甲基化分析，旨在探索NSCLC的血浆游离DNA甲基化特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE212391</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: WGBS</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 110 (涵盖11种常见实体瘤)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究使用全基因组亚硫酸盐测序技术对110例新鲜冷冻的肿瘤样本进行了DNA甲基化分析，这些样本涵盖了11种最常见的实体癌类型，旨在构建一个全面的DNA甲基化单体型图谱，以探究癌症中超越平均甲基化水平的样本内异质性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE249157</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina MethylationEPIC</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 23 (包含7例非小细胞肺腺癌、3例非小细胞肺癌G3、4例肺鳞癌)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用Illumina MethylationEPIC芯片对肺癌（包括肺腺癌、肺鳞癌等亚型）脑转移灶样本进行全基因组DNA甲基化分析，旨在研究肺癌脑转移过程中的表观遗传重编程机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE210957</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: MeDIP-seq &amp; MRE-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 52 (17 tumor vs 10 matched normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对17例原发性非小细胞肺癌（NSCLC）肿瘤组织与10例配对癌旁正常肺组织进行全基因组DNA甲基化分析，结合MeDIP-seq和MRE-seq技术，旨在比较吸烟与非吸烟患者中与肿瘤表型相关的特异性及复发性DNA甲基化改变，鉴定出包括FAM83A、SEPT9、PCDH7等在内的多个与癌症相关的差异甲基化基因启动子及重复元件区域。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE230193</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RRBS (FFPE-RRBS)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 498 (498 primary cancer patients)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在开发一种基于DNA甲基化测序的方法来预测转移性癌症的原发部位，使用福尔马林固定石蜡包埋组织提取的降解DNA构建简化代表性亚硫酸盐测序文库，通过对498例原发癌患者的训练数据集进行系统评估，构建了基于多种甲基化评估方法和机器学习算法的分子分类器，以解决癌症原发灶不明患者的诊断难题。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE226271</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: MeDIP-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6 (3 tumor vs 3 matched normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对3例肺癌组织与3例配对癌旁正常组织进行甲基化DNA免疫共沉淀测序以检测DNA甲基化水平，同时进行lncRNA测序，鉴定出255个差异甲基化基因和246个差异表达lncRNA，并发现LINC01354的甲基化差异可预测其转录，同时分析了差异甲基化相关DELs的预后价值。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE139032</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 154</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对肺腺癌（LUAD）亚型进行DNA甲基化谱分析，包括患者匹配的非恶性肺组织样本，通过启动子低甲基化等机制研究ELF3转录因子在肺腺癌中的致癌作用及其亚型特异性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE124052</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 61 (primary lung squamous cell carcinoma vs head and neck squamous cell carcinoma)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在区分头颈部鳞状细胞癌的肺转移灶与原发肺鳞状细胞癌，通过DNA甲基化谱芯片分析原发肿瘤样本，并训练三种机器学习模型（人工神经网络、支持向量机、随机森林）进行分类，在包含279例HNSC、LUSC及正常肺对照的验证队列中，人工神经网络实现了96.4%的正确分类率，并在一组有HNSC病史且发生第二肺部肿瘤的51例患者队列中进行了独立的临床验证，以指导治疗决策。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE119144</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 60</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究通过甲基化芯片分析了60例肺癌样本，旨在探究有丝分裂细胞分裂如何通过导致基因组去甲基化（尤其在晚期复制部分甲基化区域）来促进高突变负荷肿瘤的免疫逃逸，发现免疫调节通路基因富集于这些区域，且在去甲基化肿瘤中因CpG岛启动子高甲基化而转录抑制，全基因组甲基化缺失与免疫逃逸特征相关，独立于突变负荷和非整倍性，甲基化组数据表明基因组甲基化改变抵消了高突变负荷的贡献并增加了免疫治疗抵抗，且甲基化缺失比突变负荷具有更高的预测能力。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE108576</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina Infinium HumanMethylation450</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 89 (18 lung cancer brain metastases vs 71 others)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用Illumina 450K甲基化芯片对福尔马林固定石蜡包埋的脑转移瘤样本进行全基因组DNA甲基化分析，旨在对转移性脑肿瘤进行分子分类，其中包含18例肺癌脑转移样本。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE94986</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina HumanMethylation450 (Infinium 450K)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 237 (237 lung cancer cases)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究利用Infinium 450K甲基化芯片分析了来自237例肺癌患者的非肿瘤肺组织，旨在探究烟草吸烟与全表观基因组甲基化的关联，鉴定出7个与吸烟相关的低甲基化CpG位点，并在TCGA数据中验证，其中5个位点在吸烟者血液中也存在低甲基化，表明血液生物标志物可反映靶组织变化；进一步在A549肺腺癌细胞系中验证发现，这些位点附近的增强子区域在香烟烟雾暴露后被激活，并刺激了AHRR和CYP1B1等基因的表达，这些基因表达与肺癌中的吸烟相关突变有关，揭示了吸烟相关低甲基化可能是增强子激活的结果，与肺癌发生机制相关。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE83845</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina HumanMethylation27 BeadChip</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 39 (39 tumor)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对39例肺腺癌患者的肿瘤样本进行全基因组DNA甲基化分析，使用Illumina HumanMethylation27芯片检测约27,578个CpG位点的甲基化谱。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE70090</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: oxBS-Seq and BS-Seq (全基因组甲基化/羟甲基化测序)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 28 (正常与恶性肺组织配对样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 应用氧化亚硫酸盐测序技术，在配对的人正常肺与肺癌组织样本中，生成了全基因组单碱基分辨率的DNA甲基化与羟甲基化图谱，旨在揭示5mC和5hmC在肺癌发生中的动态变化及其与基因表达调控的关系。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE71398</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina Infinium HumanMethylation450 BeadChip v1.2</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 48 (24 tumor vs 24 tumor [12 hypoxic vs 12 normoxic])</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用Illumina 450K甲基化芯片对来自新鲜冷冻肿瘤组织的DNA进行全基因组DNA甲基化与羟甲基化分析，样本包括根据缺氧基因集评分确定的12例缺氧性和12例常氧性非小细胞肺癌肿瘤样本，通过糖基化和氧化处理分别检测5hmC和5mC，旨在研究肿瘤缺氧通过降低TET酶活性导致DNA高甲基化的机制及其在肿瘤抑制基因启动子区域的影响。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE63704</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina HumanMethylation450</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 129 (17 lung cancer vs 112 others)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究使用Illumina 450K芯片对支气管镜获取并液氮速冻的新鲜冷冻肺组织活检样本进行全基因组甲基化水平分析，旨在鉴定肺癌（17例）、特发性肺纤维化（37例）、慢性阻塞性肺疾病（32例）患者以及健康肺组织（43例）的特异性甲基化模式，其中肺纤维化患者基于肺部CT扫描进行分类。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE63384</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina Infinium HumanMethylation27 BeadChip</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 70 (35 tumor vs 35 adjacent non-tumor)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对35例I期肺腺癌患者的肿瘤组织及配对的癌旁非肿瘤组织进行全基因组DNA甲基化分析，使用Illumina 27K甲基化芯片检测约27,000个CpG位点，旨在鉴定候选预后生物标志物，并在独立队列中通过焦磷酸测序进行验证。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE62948</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 56 (28 tumor vs 28 paired adjacent nonmalignant)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究针对28例从不吸烟者的肺腺癌肿瘤组织及其配对的癌旁非恶性肺组织进行DNA甲基化芯片分析，旨在比较肿瘤与正常组织间的甲基化谱差异，并将差异甲基化变化与来自相同28个样本的基因表达变化进行关联分析。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE19034</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 90</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在鉴定肺腺癌中的新型肿瘤抑制基因，发现位于6q23.2的EYA4基因在分析的样本中频繁发生缺失和高甲基化，通过使用5'-氮杂胞苷评估DNA甲基化对EYA4表达的控制，并利用稳定敲低该基因的细胞通过流式细胞术和qPCR评估其在凋亡中的作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE37764</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: MeDIP-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 36 (6名患者的肿瘤与癌旁配对样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究对6名从不吸烟的韩国女性非小细胞肺腺癌患者的原发肿瘤及配对癌旁正常组织进行了多组学高通量测序分析，包括外显子组测序、RNA-seq、小RNA-seq和甲基化DNA免疫共沉淀测序，旨在整合基因组变异、表观遗传调控和基因表达谱，构建功能网络并识别驱动肺腺癌的关键通路，其中G2/M细胞周期检查点调控网络被确定为主要的失调模块。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE27902</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina GoldenGate Methylation Array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 94 (47 tumor vs 47 matched normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用来自47名个体的配对肿瘤与非肿瘤肺组织，通过Illumina GoldenGate甲基化芯片检测，计算每个CpG位点在配对样本中的甲基化变化比值，并跨个体平均以识别与非小细胞肺癌发生相关的最显著甲基化改变。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE3286</span></span><span leaf=""><span textstyle="">6</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 55 (lung adenocarcinoma vs adjacent non-tumor lung)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用来自安大略肿瘤库的肺腺癌肿瘤组织及癌旁非肿瘤肺组织进行全基因组规模的DNA甲基化芯片分析，旨在验证EDRN/Canary Foundation研究的发现。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE32861</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina Infinium HumanMethylation27 (GPL8490)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 118 (59 tumor vs 59 matched non-tumor)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用Illumina HumanMethylation27芯片对59对匹配的肺腺癌组织与非肿瘤肺组织进行全基因组DNA甲基化分析，并通过独立样本集验证，旨在鉴定肿瘤与正常组织间的差异甲基化基因，整合mRNA表达数据揭示与细胞分化、EMT、RAS/WNT信号通路及细胞周期调控相关的表观遗传失调，并发现与KRAS突变相关的肿瘤甲基化亚型。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE32484</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: MeDIP-Seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 5 (3 Dnmt3a deficient vs 2 WT)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为研究Dnmt3a缺失是否导致基因组甲基化改变，对三例Dnmt3a缺失的Kras肺肿瘤和两例野生型Kras肺肿瘤进行无偏倚的甲基化组分析，通过甲基化DNA免疫共沉淀结合高通量测序，发现Dnmt3a缺失肿瘤中低表达的基因往往在基因体区域具有较低的甲基化水平。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE16559</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array (1413 CpG loci)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 285 (肺腺癌、间皮瘤及非恶性肺组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在解决肺部肿瘤（尤其是肺腺癌和间皮瘤）病理分型困难的问题，通过分析285例样本（包括肺腺癌、间皮瘤和非恶性肺组织）中与773个癌症相关基因关联的1413个常染色体CpG位点的DNA甲基化谱，以寻找鉴别诊断标志物。使用无监督递归分割混合建模技术，发现甲基化谱类别与样本类型显著相关。在肿瘤样本中，甲基化谱类别能准确预测肿瘤类型。随机森林分类法对肿瘤CpG甲基化的分析能超过99%的准确率区分间皮瘤与肺腺癌。通过位点间比较，发现1266个CpG位点在两种肿瘤间存在显著差异甲基化，其中61%在肺腺癌中甲基化程度更高。通路分析显示，肺腺癌中差异甲基化的基因位点在细胞周期调控、DNA损伤应答、PTEN信号和凋亡信号通路中显著富集，表明基于甲基化谱的鉴别方法高度准确，揭示了疾病的独特病因，并具有临床应用潜力。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE229509</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 26</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对23例肺鳞癌（LUSC）FFPE肿瘤样本和3例健康对照进行RNA-seq分析，旨在鉴定与肿瘤发生和总生存期（OS）相关的关键分子，并通过TCGA LUSC队列验证，在早期非转移性患者中识别出与OS相关的新型预后生物标志物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE198048</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 190</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过全基因组RNA测序比较肺癌诊断时采集的病例与对照全血样本中基因表达，鉴定出与肺癌相关的候选基因，并评估了这些基因在诊断前样本中的表达，发现ANXA3、ARG1和HP的高表达与晚期肺癌患者较低的生存率显著相关，表明这些基因是晚期肺癌的诊断和预后标志物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE232569</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 95</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究是一项前瞻性设计的回顾性评估，旨在验证一个新的48基因抗叶酸反应特征（AF-PRS）在局部晚期/转移性非鳞状非小细胞肺癌患者中的预测价值，这些患者接受了含培美曲塞的铂类双药化疗。研究假设AF-PRS能筛选出对化疗有更好反应的患者，结果显示AF-PRS阳性与更长的无进展生存期（PFS）相关，但总生存期（OS）无显著差异。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE157010</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 235</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 该研究旨在验证用于识别早期肺鳞癌术后复发高风险患者的预后mRNA标志物，通过多机构前瞻性队列（Cohort II）进行验证，使用基线临床模型结合基因特征来预测患者术后生存，主要终点为3年生存期。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE157009</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 249</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 该研究为多中心前瞻性验证研究，旨在验证用于识别早期肺鳞癌术后复发高风险患者的预后mRNA特征。研究纳入了249例经手术切除的I期和II期肺鳞癌患者，主要终点为术后3年生存率，以指导辅助化疗决策或临床试验入组。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE103584</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 130</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对113例非小细胞肺癌患者进行RNA测序分析，构建影像基因组学图谱，将CT影像特征与基因表达谱相关联，并验证了识别出的基因模块与预后的相关性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE53882</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray (custom miRNA array)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 548</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用包含1888个miRNA探针的定制微阵列，成功构建了397例非小细胞肺癌患者和151例对应癌旁组织的miRNA表达谱，并成功鉴定出用于预测NSCLC预后的miRNA特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE87340</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 54</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对27例从不吸烟者的肺腺癌样本及其配对正常组织进行外显子组和mRNA测序，检测体细胞突变，并与通路失调、肿瘤表型和临床结局（患者生存）相关联，旨在发现与通路失调和患者生存高度相关的复发性突变，用于患者分层和治疗靶点开发。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE83227</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Oligonucleotide Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 254</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过微阵列分析186例肺癌样本（含139例肺腺癌）的mRNA表达谱，构建分子分类学，回顾性分析显示具有神经内分泌基因表达的肺腺癌亚类预后较差，旨在将表达谱数据与临床参数结合以辅助肺癌诊断。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE46539</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 115</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对115例接受一线TKI治疗的肺腺癌患者进行全基因组eQTL研究，整合SNP分型和基因表达谱数据，旨在揭示与无进展生存期相关的遗传变异如何通过影响已知肺癌相关基因的表达来发挥作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE77803</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 156</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究开发并验证了一个与NSCLC术后复发时间强相关的33基因特征，在一个包含156个样本的队列中进行了分析，并在多个回顾性和前瞻性队列中验证了该特征识别具有高复发风险和不同预后（包括中位生存期）的侵袭性肿瘤亚型的能力。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE67639</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray (原始数据) / qPCR (验证队列)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 1106 (非鳞状NSCLC，含多个验证队列)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 研究旨在为早期非小细胞肺癌（非鳞状）患者开发并验证一个结合肿瘤微环境基因表达特征和临床变量的死亡率风险评分，通过分析多个独立队列（包括微阵列和FFPE qPCR验证队列）的基因表达谱和生存数据（总生存期），构建了一个9基因分子预后指数，该指数能有效对I期患者进行预后分层，并与临床变量结合提供更准确的风险评估。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE68571</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 96</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对早期肺腺癌患者进行微阵列分析，通过单变量Cox分析鉴定与生存最相关的基因，基于前50个基因构建风险指数，成功区分出生存差异显著的低风险和高风险I期肺腺癌患者，并在独立样本中得到验证，旨在识别可从辅助治疗中获益的高危人群。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE68465</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 462</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对442例肺腺癌患者进行多中心、盲法验证的微阵列基因表达谱研究，旨在评估多个基于基因表达（单独或结合临床协变量）的预后模型预测总生存期的性能，模型产生的风险评分与实际患者结局显著相关，为早期肺癌提供了最大的带有广泛病理和临床注释的微阵列数据集。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE47115</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 46</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对46例早期非小细胞肺癌患者进行全基因组基因表达分析，包含无病生存期和总生存期数据，旨在评估MMP19通过多种机制促进NSCLC发生发展的假说。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE63074</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 410</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对410例早期、完全切除的非小细胞肺癌患者进行微阵列分析，验证一个15基因预后特征，用于区分预后良好和预后不良的患者。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE50081</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 181</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对181例I期和II期非小细胞肺癌（NSCLC）患者的冰冻切除肿瘤组织进行表达谱分析，包含总生存期（OS）数据，用于验证一个15基因预后分类器在独立队列（包括IA期患者）及不同组织学亚型（腺癌和鳞癌）中的预后价值。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE30219</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 307</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对293例肺癌肿瘤进行全基因组转录组分析，发现一组26个基因的表达是预后不良的强独立预测因子，并在两个独立外部人群中得到验证，用于识别具有高转移倾向和侵袭性的肿瘤亚群。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE37745</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 196</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究利用一个包含196例非小细胞肺癌（NSCLC）病例、具有临床信息和长期随访数据的新队列作为训练集，筛选具有预后影响的单基因，并通过包含5个独立肺癌队列（共860例）的荟萃分析进行验证，旨在发现与生存显著相关的生物标志物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE31210</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 226</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对226例病理I-II期肺腺癌原发样本进行全基因组表达谱分析，根据EGFR、KRAS和ALK突变状态分组，其中A组三阴性肺腺癌病例在复发和死亡方面显示出比EGFR、KRAS或ALK突变病例及B组三阴性病例更差的预后，研究旨在识别与该组预后相关的基因，用于辅助化疗患者选择和靶向治疗开发。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE28571</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 100</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对100例非小细胞肺癌患者进行基因表达谱分析，旨在鉴定与临床结局相关的基因拷贝数变化，研究包含腺癌和鳞癌亚组，其基因拷贝数增益或缺失与患者生存期长短显著相关。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE29013</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Microarray (U133 plus 2.0)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 55</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用福尔马林固定石蜡包埋（FFPE）的非小细胞肺癌肿瘤样本进行全基因组表达谱分析，旨在开发用于预测患者预后的基因特征，研究样本与临床结局的关联。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE14814</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 133</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对133例早期非小细胞肺癌（NSCLC）患者进行基因表达谱分析，包含观察组和辅助化疗组的生存数据，用于鉴定与预后相关并能预测辅助化疗（顺铂/长春瑞滨）获益的15基因特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE19188</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 156</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对156例早期非小细胞肺癌（NSCLC）的肿瘤和正常样本进行微阵列分析，鉴定了一个包含17个基因的预后特征，该特征与患者术后生存时间显示出最佳关联，并在一个规模相似的独立患者队列中进行了验证。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE997</span></span><span leaf=""><span textstyle="">1</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 27</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对27例未接受辅助化疗的非小细胞肺癌患者手术切除的肿瘤样本进行微阵列分析，根据术后2年是否复发分为复发组和非复发组，通过Cox多变量分析鉴定与复发相关的基因，发现CYP3A5基因高表达与复发相关。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE11117</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray (Novachip)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 56</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对41例未经化疗的非小细胞肺癌患者和15例肺部炎症对照患者的组织样本进行基因表达谱分析，旨在开发并验证一个用于预测生存的13基因元基因特征，并在4个独立数据集上验证了其预后价值。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE10072</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Microarray (HG-U133A)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 107</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对107例肺腺癌及配对的非癌肺组织样本进行基因表达分析，研究吸烟相关基因表达特征，并发现非癌肺组织中NEK2与TTK的表达与吸烟者肺腺癌死亡风险增加相关。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE8894</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 138</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对138例术后非小细胞肺癌患者进行微阵列分析，旨在通过基因表达谱和临床参数建立个体化复发风险预测模型，以评估无复发生存期，并在独立队列中得到验证。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE4716</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 100</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对50例连续手术且随访超过五年的非小细胞肺癌患者进行基因表达谱分析，构建了个体化预后预测分类器，用于预测患者术后五年生存或死亡，并在非鳞状细胞癌中实现了超过90%的预测准确性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE5123</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray (22,323 elements)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 51</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对51例肺鳞状细胞癌（I-III期）患者进行微阵列分析，通过比较术后36个月内无复发与18个月内复发患者的基因表达谱，鉴定出与肿瘤复发和总生存相关的基因特征，用于预测复发风险和患者预后。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE6253</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 72</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对72例I期非小细胞肺癌患者进行微阵列分析，通过整合多个研究的数据并校正系统偏倚，鉴定出与生存时间（短于2年和超过5年）相关的64个基因表达特征，用于预测哪些患者可能从更积极的治疗中获益。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE3593</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 198</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对198例早期非小细胞肺癌患者进行基因组学分析，旨在优化辅助治疗的预后判断，研究终点包含复发和结局。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE4882</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 125</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对125例非小细胞肺癌患者进行微阵列分析，旨在利用基因表达谱预测患者术后复发、转移及总生存期，研究构建了基于5个基因的决策树模型，并在独立队列中验证了其对复发和OS的预测能力。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE4573</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 130</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对130例肺鳞癌患者进行微阵列分析，通过基因特征区分高风险与低风险患者，用于预后分析。</span></section></li></ul><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section data-style="display: inline-block; width: 16px; height: 16px; vertical-align: top; overflow: hidden; background-color: rgba(255, 255, 255, 0); border-width: 1px; border-radius: 26px; border-style: solid; border-color: rgb(152, 186, 189); box-sizing: border-box;"><svg viewbox="0 0 1 1" role="img" aria-label="插图"></svg></section></section></section><section><section powered-by="xiumi.us"><section data-style="display: inline-block; width: 16px; height: 16px; vertical-align: top; overflow: hidden; background-color: rgb(251, 228, 151); border-width: 0px; border-radius: 26px; border-style: none; border-color: rgb(62, 62, 62); box-sizing: border-box;"><svg viewbox="0 0 1 1" role="img" aria-label="插图"></svg></section></section></section><section><section powered-by="xiumi.us"><section data-style="background-color: rgb(152, 186, 189); height: 1px; box-sizing: border-box;"><svg viewbox="0 0 1 1" role="img" aria-label="插图"></svg></section></section></section></section><p powered-by="xiumi.us"><span leaf="">偷偷告诉你，我们在B站还有优质文章分享视频哦~</span></p><p><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8e4saCVV3UImjUtzXGXBXOWvZ7licdDy0icNArmd86pd3RVUXU7Iedsg7zMtOODucZia0FPgT2ovZYiaw/640?wx_fmt=other&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1#imgIndex=5" alt="图片" data-ratio="1" data-s="300,640" data-type="jpeg" data-w="960" data-imgfileid="100028841" src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8e4saCVV3UImjUtzXGXBXOWvZ7licdDy0icNArmd86pd3RVUXU7Iedsg7zMtOODucZia0FPgT2ovZYiaw/640?wx_fmt=other&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1#imgIndex=5"></span></p></section><p><mp-style-type data-value="10000"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/ns_Xb7Q9ZdPx6G1i168_EA",target="_blank" rel="noopener noreferrer">原文链接</a>
